[1]
|
Miettinen, M. and Lasota, J. (2006) Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis. Archives of Pathology & Laboratory Medicine, 130, 1466-1478. https://doi.org/10.5858/2006-130-1466-GSTROM
|
[2]
|
Martin-Broto, J., Martinez-Marin, V., Serrano, C., Hindi, N., López-Guerrero, J.A., Ramos-Asensio, R., Vallejo-Benitez, A., Marcilla-Plaza, D. and González-Cámpora, R. (2017) Gastrointestinal Stromal Tumors (GISTs): SEAP-SEOM Consensus on Pathologic and Molecular Diagnosis. Clinical and Translational Oncology, 19, 536-545. https://doi.org/10.1007/s12094-016-1581-2
|
[3]
|
Stamatakos, M., Douzinas, E., Stefanaki, C., Safioleas, P., Polyzou, E., Levidou, G. and Safioleas, M. (2009) Gastrointestinal Stromal Tumor. World Journal of Surgical Oncology, 7, 1-9. https://doi.org/10.1186/1477-7819-7-61
|
[4]
|
Goettsch, W.G., Bos, S.D., Breekveldt-Postma, N., Casparie, M., Herings, R.M. and Hogendoorn, P.C. (2005) Incidence of Gastrointestinal Stromal Tumours Is Underestimated: Results of a Nation-Wide Study. European Journal of Cancer, 41, 2868-2872. https://doi.org/10.1016/j.ejca.2005.09.009
|
[5]
|
Miettinen, M. and Lasota, J. (2003) Gastrointestinal Stromal Tumors (GISTs): Definition, Occurrence, Pathology, Differential Diagnosis and Molecular Genetics. Polish Journal of Pathology, 54, 3-24.
|
[6]
|
Cassier, P.A., Ducimetière, F., Lurkin, A., Ranchère-Vince, D., Scoazec, J.Y., Bringuier, P.P., Decouvelaere, A., Méeus, P., Cellier, D., Blay, J.Y. and Ray-Coquard, I. (2010) A Prospective Epidemiological Study of New Incident GISTs during Two Consecutive Years in Rhône Alpes Region: Incidence and Molecular Distribution of GIST in a European Region. British Journal of Cancer, 103, 165-170. https://doi.org/10.1038/sj.bjc.6605743
|
[7]
|
Kawanowa, K., Sakuma, Y., Sakurai, S., Hishima, T., Iwasaki, Y., Saito, K., Hosoya, Y., Nakajima, T. and Funata, N. (2006) High Incidence of Microscopic Gastrointestinal Stromal Tumors in the Stomach. Human Pathology, 37, 1527-1535. https://doi.org/10.1016/j.humpath.2006.07.002
|
[8]
|
Søreide, K., Sandvik, O.M., Søreide, J.A., Giljaca, V., Jureckova, A. and Bulusu, V.R. (2016) Global Epidemiology of Gastrointestinal Stromal Tumours (GIST): A Systematic Review of Population-Based Cohort Studies. Cancer Epidemiology, 40, 39-46. https://doi.org/10.1016/j.canep.2015.10.031
|
[9]
|
Miettinen, M., Fetsch, J.F., Sobin. L.H. and Lasota, J. (2006) Gastrointestinal Stromal Tumors in Patients with Neurofibromatosis 1: A Clinicopathologic and Molecular Genetic Study of 45 Cases. The American Journal of Surgical Pathology, 30, 90-96. https://doi.org/10.1097/01.pas.0000176433.81079.bd
|
[10]
|
Maeyama, H., Hidaka, E., Ota, H., Minami, S., Kajiyama, M., Kuraishi, A., Mori, H., Matsuda, Y., Wada, S., Sodeyama, H. and Nakata, S. (2001) Familial Gastrointestinal Stromal Tumor with Hyperpigmentation: Association with a Germline Mutation of the C-Kit Gene. Gastroenterology, 120, 210-215. https://doi.org/10.1053/gast.2001.20880
|
[11]
|
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H. and Kitamura, Y. (1998) Familial Gastrointestinal Stromal Tumours with Germline Mutation of the KIT Gene. Nature Genetics, 19, 323-324. https://doi.org/10.1038/1209
|
[12]
|
Beghini, A., Tibiletti, M., Roversi, G., Chiaravalli, A., Serio, G., Capella, C. and Larizza, L. (2001) Germline Mutation in the Juxtamembrane Domain of the Kit Gene in a Family with Gastrointestinal Stromal Tumors and Urticaria Pigmentosa. Cancer: Interdisciplinary International Journal of the American Cancer Society, 92, 657-662. https://doi.org/10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D
|
[13]
|
Chompret, A., Kannengiesser, C., Barrois, M., Terrier, P., Dahan, P., Tursz, T., Lenoir, G.M. and Bressac-De Paillerets, B. (2004) PDGFRA Germline Mutation in a Family with Multiple Cases of Gastrointestinal Stromal Tumor. Gastroenterology, 126, 318-321. https://doi.org/10.1053/j.gastro.2003.10.079
|
[14]
|
Emory, T.S., Sobin, L.H., Lukes, L., Lee, D.H. and O’Leary, T.J. (1999) Prognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors: Dependence on Anatomic Site. The American Journal of Surgical Pathology, 23, 82-87. https://doi.org/10.1097/00000478-199901000-00009
|
[15]
|
Reith, J.D., Goldblum, J.R., Lyles, R.H. and Weiss, S.W. (2000) Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of Outcome. Modern Pathology, 13, 577-585. https://doi.org/10.1038/modpathol.3880099
|
[16]
|
Erlandson, R.A., Klimstra, D.S. and Woodruff, J.M. (1996) Subclassification of Gastrointestinal Stromal Tumors Based on Evaluation by Electron Microscopy and Immunohistochemistry. Ultrastructural Pathology, 20, 373-393. https://doi.org/10.3109/01913129609016340
|
[17]
|
Parab, T.M., DeRogatis, M.J., Boaz, A.M., Grasso, S.A., Issack, P.S., Duarte, D.A., Urayeneza, O., Vahdat, S., Qiao, J.H. and Hinika, G.S. (2019) Gastrointestinal Stromal Tumors: A Comprehensive Review. Journal of Gastrointestinal Oncology, 10, 144. https://doi.org/10.21037/jgo.2018.08.20
|
[18]
|
Caterino, S., Lorenzon, L., Petrucciani, N., Iannicelli, E., Pilozzi, E., Romiti, A., Cavallini, M. and Ziparo, V. (2011) Gastrointestinal Stromal Tumors: Correlation between Symptoms at Presentation, Tumor Location and Prognostic Factors in 47 Consecutive Patients. World Journal of Surgical Oncology, 9, 1-0. https://doi.org/10.1186/1477-7819-9-13
|
[19]
|
Menge, F., Jakob, J., Kasper, B., Smakic, A., Gaiser, T. and Hohenberger, P. (2018) Clinical Presentation of Gastrointestinal Stromal Tumors. Visceral Medicine, 34, 335-340. https://doi.org/10.1159/000494303
|
[20]
|
Sorour, M.A., Kassem, M.I., Ghazal, A.E., El-Riwini, M.T. and Nasr, A.A. (2014) Gastrointestinal Stromal Tumors (GIST) Related Emergencies. International Journal of Surgery, 12, 269-280. https://doi.org/10.1016/j.ijsu.2014.02.004
|
[21]
|
Constantin, V.D., Socea, B., Popa, F., Carap, A.C., Popescu, G., Vlădescu, T.E., Ceauşu, Z., Berteşteanu, Ş.V. and Ceauşu, M.C. (2014) A Histopathological and Immunohistochemical Approach of Surgical Emergencies of GIST. An Interdisciplinary Study. Romanian Journal of Morphology and Embryology, 55, 619-627.
|
[22]
|
Jakob, J., Mussi, C., Ronellenfitsch, U., Wardelmann, E., Negri, T., Gronchi, A. and Hohenberger, P. (2013) Gastrointestinal Stromal Tumor of the Rectum: Results of Surgical and Multimodality Therapy in the Era of Imatinib. Annals of Surgical Oncology, 20, 586-592. https://doi.org/10.1245/s10434-012-2647-1
|
[23]
|
Yacob, M., Inian, S. and Sudhakar, C.B. (2015) Gastrointestinal Stromal Tumours: Review of 150 Cases from a Single Centre. Indian Journal of Surgery, 77, 505-510. https://doi.org/10.1007/s12262-013-0899-z
|
[24]
|
Casali, P.G., Blay, J.Y., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J.V. and Boye, K. (2022) Gastrointestinal Stromal Tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 33, 20-33.
|
[25]
|
Jiang, Z.X., Zhang, S.J., Peng, W.J. and Yu, B.H. (2013) Rectal Gastrointestinal Stromal Tumors: Imaging Features with Clinical and Pathological Correlation. World Journal of Gastroenterology: WJG, 19, 3108. https://doi.org/10.3748/wjg.v19.i20.3108
|
[26]
|
Tateishi, U., Hasegawa, T., Satake, M. and Moriyama, N. (2003) Gastrointestinal Stromal Tumor: Correlation of Computed Tomography Findings with Tumor Grade and Mortality. Journal of Computer Assisted Tomography, 27, 792-798. https://doi.org/10.1097/00004728-200309000-00018
|
[27]
|
Scarpa, M., Bertin, M., Ruffolo, C., Polese, L., D’Amico, D.F. and Angriman, I. (2008) A Systematic Review on the Clinical Diagnosis of Gastrointestinal Stromal Tumors. Journal of Surgical Oncology, 98, 384-392. https://doi.org/10.1002/jso.21120
|
[28]
|
Sandrasegaran, K., Rajesh, A., Rushing, D.A., Rydberg, J., Akisik, F.M. and Henley, J.D. (2005) Gastrointestinal Stromal Tumors: CT and MRI Findings. European Radiology, 15, 1407-1414. https://doi.org/10.1007/s00330-005-2647-7
|
[29]
|
Liegl, B., Hornick, J.L., Corless, C.L. and Fletcher, C.D. (2009) Monoclonal Antibody DOG1.1 Shows Higher Sensitivity than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes. The American Journal of Surgical Pathology, 33, 437-446. https://doi.org/10.1097/PAS.0b013e318186b158
|
[30]
|
Novelli, M., Rossi, S., Rodriguez-Justo, M., Taniere, P., Seddon, B., Toffolatti, L., Sartor, C., Hogendoorn, P.C., Sciot, R., Van Glabbeke, M. and Verweij, J. (2010) DOG1 and CD117 Are the Antibodies of Choice in the Diagnosis of Gastrointestinal Stromal Tumours. Histopathology, 57, 259-270. https://doi.org/10.1111/j.1365-2559.2010.03624.x
|
[31]
|
Miettinen, M., Wang, Z.F. and Lasota, J. (2009) DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors: A Study of 1840 Cases. The American Journal of Surgical Pathology, 33, 1401-1408. https://doi.org/10.1097/PAS.0b013e3181a90e1a
|
[32]
|
West, R.B., Corless, C.L., Chen, X., Rubin, B.P., Subramanian, S., Montgomery, K., Zhu, S., Ball, C.A., Nielsen, T.O., Patel, R. and Goldblum, J.R. (2004) The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status. The American Journal of Pathology, 165, 107-113. https://doi.org/10.1016/S0002-9440(10)63279-8
|
[33]
|
Rossi, S., Gasparotto, D., Miceli, R., Toffolatti, L., Gallina, G., Scaramel, E., Marzotto, A., Boscato, E., Messerini, L., Bearzi, I. and Mazzoleni, G. (2015) KIT, PDGFRA, and BRAF Mutational Spectrum Impacts on the Natural History of Imatinib-Naive Localized GIST. The American Journal of Surgical Pathology, 39, 922-930. https://doi.org/10.1097/PAS.0000000000000418
|
[34]
|
Wozniak, A., Rutkowski, P., Schöffski, P., Ray-Coquard, I., Hostein, I., Schildhaus, H.U., Le Cesne, A., Bylina, E., Limon, J., Blay, J.Y. and Siedlecki, J.A. (2014) Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST. Clinical Cancer Research, 20, 6105-6116. https://doi.org/10.1158/1078-0432.CCR-14-1677
|
[35]
|
Mussi, C., Schildhaus, H.U., Gronchi, A., Wardelmann, E. and Hohenberger, P. (2008) Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1. Clinical Cancer Research, 14, 4550-4555. https://doi.org/10.1158/1078-0432.CCR-08-0086
|
[36]
|
Chun, H.J., Byun, J.Y., Chun, K.A., Rha, S.E., Jung, S.E., Lee, J.M. and Shinn, K.S. (1998) Gastrointestinal Leiomyoma and Leiomyosarcoma: CT Differentiation. Journal of Computer Assisted Tomography, 22, 69-74. https://doi.org/10.1097/00004728-199801000-00012
|
[37]
|
Levy, A.D., Remotti, H.E., Thompson, W.M., Sobin, L.H. and Miettinen, M. (2003) Gastrointestinal Stromal Tumors: Radiologic Features with Pathologic Correlation. Radiographics, 23, 283-304. https://doi.org/10.1148/rg.232025146
|
[38]
|
Ghanem, N., Altehoefer, C., Furtwängler, A., Winterer, J., Schäfer, O., Springer, O., Kotter, E. and Langer, M. (2003) Computed Tomography in Gastrointestinal Stromal Tumors. European Radiology, 13, 1669-1678. https://doi.org/10.1007/s00330-002-1803-6
|
[39]
|
Burkill, G.J., Badran, M., Al-Muderis, O., Meirion Thomas, J., Judson, I.R., Fisher, C. and Moskovic, E.C. (2003) Malignant Gastrointestinal Stromal Tumor: Distribution, Imaging Features, and Pattern of Metastatic Spread. Radiology, 226, 527-532. https://doi.org/10.1148/radiol.2262011880
|
[40]
|
Le Cesne, A., Ray-Coquard, I., Bui, B.N., Adenis, A., Rios, M., Bertucci, F., Duffaud, F., Chevreau, C., Cupissol, D., Cioffi, A. and Emile, J.F. (2010) Discontinuation of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumours after 3 Years of Treatment: An Open-Label Multicentre Randomised Phase 3 Trial. The Lancet Oncology, 11, 942-949. https://doi.org/10.1016/S1470-2045(10)70222-9
|
[41]
|
Joensuu, H., Vehtari, A., Riihimäki, J., et al. (2012) Risk of Recurrence of Gastrointestinal Stromal Tumour after Surgery: An Analysis of Pooled Population-Based Cohorts. The Lancet Oncology, 13, 265-274. https://doi.org/10.1016/S1470-2045(11)70299-6
|
[42]
|
Joensuu, H., Eriksson, M., Hall, K.S., Hartmann, J., Pink, D., Schütte, J., Ramadori, G., Hohenberger, P., Duyster, J., Al-Batran, S.E. and Schlemmer, M. (2012) One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial. JAMA, 307, 1265-1272. https://doi.org/10.1001/jama.2012.347
|
[43]
|
Čolović, R., Micev, M., Matić, S., Čolović, N., Grubor, N. and Atkinson, D.H. (2013) Malignant Stromal Tumor of the Stomach with Giant Cystic Liver Metastases Prior to Treatment with Imatinib Mesylate. Vojnosanitetski Pregled, 70, 225-228. https://doi.org/10.2298/VSP1302225C
|
[44]
|
Miettinen, M., Sobin, L.H. and Lasota, J. (2005) Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases with Long-Term Follow-Up. The American Journal of Surgical Pathology, 29, 52-68. https://doi.org/10.1097/01.pas.0000146010.92933.de
|
[45]
|
Demetri, G.D., van Oosterom, A.T., Garrett, C.R., Blackstein, M.E., Shah, M.H., Verweij, J., McArthur, G., Judson, I.R., Heinrich, M.C., Morgan, J.A. and Desai, J. (2006) Efficacy and Safety of Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumour after Failure of Imatinib: A Randomised Controlled Trial. The Lancet, 368, 1329-1338. https://doi.org/10.1016/S0140-6736(06)69446-4
|
[46]
|
Son, M.K., Ryu, M.H., Park, J.O., Im, S.A., Kim, T.Y., Lee, S.J., Ryoo, B.Y., Park, S.R. and Kang, Y.K. (2017) Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program. Cancer Research and Treatment: Official Journal of Korean Cancer Association, 49, 350. https://doi.org/10.4143/crt.2016.067
|
[47]
|
Joensuu, H., Martin-Broto, J., Nishida, T., Reichardt, P., Schöffski, P. and Maki, R.G. (2015) Follow-Up Strategies for Patients with Gastrointestinal Stromal Tumour Treated with or without Adjuvant Imatinib after Surgery. European Journal of Cancer, 51, 1611-1617. https://doi.org/10.1016/j.ejca.2015.05.009
|
[48]
|
Meijer, S., Peretz, T., Gaynor, J.J., Tan, C., Hajdu, S.I. and Brennan, M.F. (1990) Primary Colorectal Sarcoma: A Retrospective Review and Prognostic Factor Study of 50 Consecutive Patients. Archives of Surgery, 125, 1163-1168. https://doi.org/10.1001/archsurg.1990.01410210089014
|